Fate and Effects of Allelochemicals
J. Agric. Food Chem., Vol. 54, No. 4, 2006 997
1
acylation forced us to use acetic acid, in which AAMPO
precipitated once the reaction was completed. Overall yield from
5-methoxy-2-nitrophenol was 56%. It is interesting to note the
high reactivity difference between the amino group of ami-
nophenoxazines APO and AAMPO (Table 1C). Acetylation of
APO (Table 1C) can be made in good yields by means of the
usual pyridine procedure (25), yielding 2-acetamidophenoxazin-
3-one (AAPO, Table 1C), whereas base-catalyzed acylation
did not proceed successfully with AMPO.
- CO2 - 1]+); H NMR (MeOH-d4, 400 MHz) δ 3.85 [s, 2H
(H-2)], 6.90 [ddd, 1H, J ) 8.0, 7.0, 1.0 Hz (H-4′)], 6.98 [dd,
1H, J ) 8.0, 1.0 Hz (H-6′)], 7.06 [ddd, 1H, J ) 8.0, 7.0, 1.0
Hz (H-5′)], 8.08 [dd, 1H, J ) 8.0, 1.0 Hz (H-3′)]; 13C NMR
(MeOH-d4, 100 MHz) δ 55.4 (C-2), 110.8 (C-6′), 120.4 (C-4′),
121.3 (C-5′), 124.9 (C-3′), 127.2 (C-1′), 149.8 (C-2′), 165.6 (C-
3), 170.6 (C-1).
Synthesis of N-(2-Hydroxy-4-methoxyphenyl)malonamic
Acid (HMPMA, Table 1D). Reactions and conditions employed
are summarized in Scheme 5. The same synthetic methodology
as the employed for HMPA obtention was used for the
preparation of its analogue, HMPMA, from 5-methoxy-2-
nitrophenol (purchased from Sigma Aldrich Co., used as
received) (10). The structures of the synthetic intermediates were
2-Amino-7-methoxyphenoxazin-3-one (AMPO, Table 1C):
λ
max (nm) 235.0; FTIR (cm-1) 3450, 3299, 1577, 847; MS (ESI),
m/z found for C13H10N2O3 243 (100%, [M + 1]+); H NMR
(MeOH-d4, 400 MHz) δ 3.85 [s, 3H (-OCH3)], 6.33 [s, 1H
(H-4)], 6.35 [s, 1H (H-1)], 7.01 [dd, 1H, J ) 7.0, 2.7 Hz (H-
8)], 7.11 [d, 1H, J ) 2.7 Hz (H-6)], 7.64 [d, 1H, J ) 9.0 Hz
(H-9); 13C NMR (MeOH-d4, 100 MHz) δ 56.1 (-OCH3), 98.8
(C-1), 100.1 (C-6), 103.3 (C-4), 113.5 (C-8), 128.4 (C-9a), 129.0
(C-9), 143.3 (C-5a), 145.7 (C-2), 146.6 (C-10a), 148.6 (C-4a),
160.0 (C-7), 179.9 (C-2).
1
1
confirmed by H NMR.
O-tert-Butyldimethylsilyl-5-methoxy-2-nitrophenol (15): 1H
NMR (CDCl3, 400 MHz) δ 7.90 [1H, d, J ) 9.0 Hz (H-3)],
6.52 [1H, dd, J ) 9.0, 2.6 Hz (H-4)], 6.40 [1H, d, J ) 2.6 Hz
(H-6)], 3.82 [s, 3H (CH3O)], 1.00 [s, 9H (H-8)], 0.24 [s, 6H
(H-7)].
2-Acetamido-7-methoxyphenoxazin-3-one (AAMPO, Table
1C): λmax (nm) 235.4; FTIR (cm-1) 3298, 2924, 1526, 1257,
805; MS (ESI), m/z found for C15H12N2O4 285 (100%, [M +
1
O-tert-Butyldimethylsilyl-2-amino-5-methoxyphenol (16): H
NMR (CDCl3, 400 MHz) δ 6.63 [1H, d, J ) 8.3 Hz (H-3)],
6.39 [1H, dd, J ) 8.3, 2.6 Hz (H-4)], 6.36 [1H, d, J ) 2.6 Hz
(H-6)], 3.70 [s, 3H (CH3O)], 1.02 [s, 9H (H-8)], 0.25 [s, 6H
(H-7)].
N-(2′-tert-Butyldimethylsilyloxy-4′-methoxyphenyl)malon-
amic acid ethyl ester (17): 1H NMR (CDCl3, 400 MHz) δ 8.07
[1H, d, J ) 8.9 Hz (H-6′)], 6.39 [2H, m, (H-3′, H-5′)], 4.15
[2H, q, J ) 7.2 Hz (H-9′)], 3.66 [3H, s, (CH3O)], 3.37 [2H, s,
(H-2)], 1.20 [3H, t, J ) 7.2 Hz (H-10′)], 1.16 [9H, s, (H-8′)],
0.23 [s, 6H (H-7′)].
N-(2-Hydroxy-7-methoxyphenyl)malonamic acid (HMPMA,
Table 1D): λmax (nm) 208.1, 249.8, 287.4; FTIR (cm-1) 3215,
3081, 1698, 1433, 1202; MS (ESI), m/z found for C10H11NO5
226 (100%, [M + 1]+); 1H NMR (MeOH-d4, 400 MHz) δ 3.30
[s, 2H (H-2)], 3.52 [s, 3H (-OCH3)], 6.19 [dd, 1H, J ) 2.0,
9.0 Hz (H-5′)], 6.25 [d, 1H, J ) 2.0 Hz (H-3′)], 7.38 [d, 1H, J
) 9.0 Hz (H-6′)]; 13C NMR (MeOH-d4, 100 MHz) δ 41.9 (C-
2), 54.8 (-OCH3), 102.0 (C-3′), 104.6 (C-5′), 119.0 (C-1′),
123.9 (C-6′), 150.1 (C-2′), 158.5 (C-4′), 166.3 (C-3), 170.8 (C-
1).
The synthetic procedures described above yielded HMPA and
HMPMA in a 68% overall yield after four reactions. After two
reaction steps, Friebe et al. reported yields of 66% for HPMA
and 45% for HMPMA (31). In addition to the yield increase at
HMPMA obtention, the methods described here avoided the
undesired dimerizations and provided useful intermediates for
further research on benzoxazinone bioactivity and modes of
action.
1
1]+); H NMR (CDCl3, 400 MHz) δ 2.20 [s, 3H (-OCCH3)],
δ 3.87 [s, 3H (-OCH3)], 6.38 [s, 1H (H-4)], 6.83 [d, 1H, J )
3.0 Hz (H-6)], 6.94, [dd, 1H, J ) 9.0, 3.0 Hz (H-8)], 7.72 [d,
1H, J ) 9.0 Hz (H-9)], 8.36 [s, 1H (H-1)]; 13C NMR (CDCl3,
100 MHz) δ 25.3 (-OCCH3), 56.1 (-OCH3), 91.5 (C-4), 99.8
(C-6), 103.8 (C-8), 114.7 (C-9), 126.9 (C-9a), 131.2 (C-1), 140.5
(C-5a), 144.4 (C-4a), 147.3 (C-2), 149.5 (C-10a), 159.4 (C-7),
179.3 (C-2).
Synthesis of N-(2-Hydroxyphenyl)malonamic Acid (HPMA,
Table 1D). To avoid the inconvenience of the coexistence of
amino and hydroxyl moieties (dimerization of nitrophenols to
give aminophenoxazines), a procedure in which aromatic
nitrogen could be functionalized with the hydroxyl moiety
protected was optimized. 2-Nitrophenol was protected by
generating its tert-butyldimethylsilyl ether. After this, the nitro
group was reduced to amino by catalytic hydrogenation. This
2-amino-tert-butyldimethylsilyloxybenzene has potential utility
in the obtention of heterocycle ring-opened derivatives of
benzoxazinones, which have been proposed as metabolic
intermediates of natural benzoxazinones with an important role
in their biological activity (27). Once the amino group was
obtained, the side chain was introduced by amidation with ethyl
3-chloro-3-oxopropionate. The final alkaline hydrolysis afforded
the final desired product by cleaving the silyl ether and the ethyl
ester simultaneously. The structures of the synthetic intermedi-
1
ates were confirmed by H NMR.
O-tert-Butyldimethylsilyl-2-nitrophenol (7): 1H NMR (CDCl3,
400 MHz) δ 7.77 [1H, dd, J ) 1.6, 8.1 Hz (H-3)], 7.41 [m, 2H
(H-4, H-5)], 6.99 [m, 1H (H-6)], 0.99 [s, 9H (H-8)], 0.24 [s,
6H (H-7)].
Synthesis of DIMBOA Analogues Ethyl 5-Methoxy-2-
nitrophenylacetate (11), 4-Hydroxy-7-methoxy-(2H)-1,4-ben-
zoxazin-3(4H)-one (12), 7-Methoxy-(2H)-1,4-benzoxazin-
3(4H)-one (13), and 4-Acetoxy-7-methoxy-(2H)-1,4-benzoxazin-
3(4H)-one (14). To obtain these compounds, the same
methodology as the one employed for the obtention of DIBOA
analogues 2, 3, 4 and 5, respectively, was used (see above).
Analytical data for 11-13 matched exactly those previously
reported by Atkinson et al. (27). Compound 14 had the same
spectral data as those previously reported by Hashimoto et al.
(71).
O-tert-Butyldimethylsilyl-2-aminophenol (8): 1H NMR (CDCl3,
400 MHz) δ 7.78 [1H, dd, J ) 1.6, 8.0 Hz (H-6)], 7.42 [1H,
ddd, J ) 1.6, 8.0, 8.0 Hz (H-4)], 6.99 [m, 2H (H-3, H-5)], 0.99
[s, 9H (H-8)], 0.25 [s, 6H (H-7)].
N-(2′-tert-Butyldimethylsilyloxyphenyl)malonamic acid ethyl
1
ester (9): H NMR (CDCl3, 400 MHz) δ 8.28 [m, 1H (H-6′)],
6.90 [m, 2H (H-4′, H-5′)], 6.84 [m, 1H (H-3′)], 4.19 [2H, q, J
) 7.7 Hz (H-9′)], 3.43 [2H, s, (H-2)], 1.21 [3H, t, J ) 7.7 Hz
(H-10′)], 0.99 [9H, s, (H-8′)], 0.27 [s, 6H (H-7′)].
Reactions and conditions are summarized in Scheme 5. The
starting material employed was 5-methoxy-2-nitrophenol (10)
(purchased from Sigma Aldrich Co., used as received). The
synthesis of these compounds was made to obtain HMBOA in
N-(2-Hydroxyphenyl)malonamic acid (HPMA, Table 1D):
λ
max (nm) ) 208.9, 243.5, 283.7; FTIR (cm-1) 3292, 2924, 1723,
1542, 1254; MS (ESI), m/z found for C9H9NO4 150 (67%, [M